1 – 6 of 6
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Trajectories of cognitive processing speed and physical disability over 11 years following initiation of a first multiple sclerosis disease-modulating therapy
2023) In Journal of Neurology, Neurosurgery and Psychiatry(
- Contribution to journal › Article
-
Mark
Predictors of patient-reported fatigue symptom severity in a nationwide multiple sclerosis cohort
(
- Contribution to journal › Article
- 2022
-
Mark
Effectiveness of first generation disease-modifying therapy to prevent conversion to secondary progressive multiple sclerosis
(
- Contribution to journal › Article
- 2017
-
Mark
Guidelines for the use of magnetic resonance imaging in diagnosing and monitoring the treatment of multiple sclerosis : Recommendations of the Swedish Multiple Sclerosis Association and the Swedish Neuroradiological Society
(
- Contribution to journal › Article
- 2011
-
Mark
A Swedish national post-marketing surveillance study of natalizumab treatment in multiple sclerosis
(
- Contribution to journal › Article
- 2008
-
Mark
Diagnostic, prognostic and management aspects of different types of multiple sclerosis
(
- Thesis › Doctoral thesis (compilation)